Lyposomal doxorubicin (Caelyx), cyclophosphamide - Rituximab (DC-R) plus GM-CSF as a salvage therapy in B-diffuse large cell lymphoma (B-DLCL) after autologous stem cell transplantation (ASCT) failure.
2005-01-01 Olivieri, Attilio; Montanari, M; Capelli, D; Scortechini, I; Gini, G; Trappolini, S; Leoni, Pietro
Thalidomide, dexamethasone and pegylated-liposomal doxorubicin (ThaDD) for untreated multiple myeloma patients aged over 65 years.
2005-01-01 Offidani, M; Corvatta, L; Marconi, M; Visani, G; Alesiani, F; Brunori, M; Galieni, P; Catarini, M; Burattini, M; Centurioni, R; Rupoli, S; Scortechini, Ar; Giuliodori, L; Candela, M; Capelli, D; Montanari, M; Olivieri, Attilio; Piersantelli, Mn; Leoni, Pietro
Reduced-intensity conditioning (RIC) followed by allogeneic stem cell transplantation (SCT) for relapsed lymphomas: Impact of pre-transplantation factors on long-term outcome.
2005-01-01 Corradini, P; Dodero, A; Bregni, M; Ciceri, F; Olivieri, Attilio; Farina, L; Valagussa, P; Scime, R; Locasciulli, A; Patriarca, F; Gianni, Am; Tarella, C.
Reduced-intensity conditioning followed by allogeneic stem cell transplantation (allo-SCT) is an effective salvage treatment for peripheral T-cell non-Hodgkin's lymphoma (PTCL)
2005-01-01 Corradini, P; Dodero, A; Bregni, M; Zallio, F; Farina, L; Rambaldi, A; Patriarca, F; Olivieri, Attilio; Bonifazi, F; Gianni, Am; Tarella, C.
Rituximab-supplemented high-dose sequential chemotherapy (HDS) has superior response rate and event-free survival (EFS) compared to R-CHOP in poor risk follicular lymphoma (FL) at diagnosis: Results from a multicenter randomized GITMO trial.
2005-01-01 Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Patti, C; Rambaldi, A; Liberati, Am; Musso, M; Pulsoni, A; Olivieri, Attilio; Pavone, E; Pogliani, E; Scalabrini, Dr; Gallamini, A; Callea, V; Mantoan, B; Boccadoro, M; Majolino, I; Corradini, P; Gianni, Am; Tarella, C.
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression
2006-01-01 Olivieri, Attilio; SVEGLIATI BARONI, Silvia; Bacigalupo, A; Campelli, N; Piaggio, S; Luchetti, MICHELE MARIA; Trappolini, S; Poloni, Antonella; Leoni, Pietro; Gabrielli, Armando
High incidence of EBV-reactivation and PTLD in adults receiving a cord blood transplant with reduced-intensity conditioning regimen
2006-01-01 Gini, G; Poloni, Antonella; Mancini, G; Trappolini, S; Montanari, M; Capelli, D; Troiani, E; Scortechini, I; Re, R; Manzin, A; Leoni, Pietro; Olivieri, Attilio
Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
2006-01-01 Majolino, I; Carnevalli, E; Locasciulli, A; Di Bartolomeo, P; Scime, R; Corradini, P; Selleri, M; Narni, F; Musso, M; Bregni, M; Olivieri, Attilio; De Fabritiis, P; Pogliani, L; Ruscio, C; Bacigalupo, A.
Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin and Hodgkin's lymphomas
2006-01-01 Corradini, P; Dodero, A; Bregni, M; Olivieri, Attilio; Valagussa, P; Farina, L; Milani, R; Scime, R; Rambaldi, A; Bonifazi, F; Patriarca, F; Locasciulli, A; Bacigalupo, A; Gianni, A; Tarella, C.
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders.
2006-01-01 Bacigalupo, Andrea; van Lint, Maria Teresa; Olivieri, Attilio; Casini, Marco; Angelucci, Emanuele; Narni, Franco; Selleri, Carmine; Di Bartolomeo, Paolo; Ciceri, Fabio; Fanin, Renato
Reduced-intensity allogeneic stem cell transplantation is an effective salvage strategy for relapsed/refractory peripheral T-cell non-Hodgkin lymphomas
2007-01-01 Corradini, P.; Dodero, A.; Narni, F.; Fanin, R.; Matteucci, P.; Ciceri, F.; Scime, R.; Farina, L.; Carniti, C.; Rambaldi, A.; Bonifazi, F.; Di Bartolomeo, P.; Olivieri, Attilio; Benedetti, F.; Console, G.; Angelucci, E.; Gianni, A. M.; Tarella, C.
Early and late non relapse mortality in 2500 adults receiving ASCT for AML: a GITMO survey
2007-01-01 Olivieri, Attilio; Bruno, B.; Brunori, M.; Bacigalupo, A.; Meloni, G.; Bosi, A.
Clinical and molecular results of the multicenter randomized GITMO-IIL, trial in poor risk follicular lymphoma (FL) at diagnosis: Rituximab-supplemented high-dose sequential chemotherapy (R-HDS) is superior to CHOP-R in molecular remissions rate, EFS and PFS.
2006-01-01 Ladetto, Marco; de Marco, Federica; Benedetti, Fabio; Vitolo, Umberto; Patti, Caterina; Rambaldi, Alessandro; Liberati, Anna Marina; Musso, Maurizio; Pulsoni, Alessandro; Olivieri, Attilio; Pavone, Enzo; Pogliani, Enrico; Scalabrini, Delia Rota; Gallamini, Andrea; Callea, Vincenzo; Ricca, Irene; Boccadoro, Mario; Majolino, Ignazio; Corradini, Paolo; Gianni, Alessandro M.; Tarella, Corrado
Feasibility of autologous transplantation in elderly multiple myeloma (MM) patients receiving thadd as induction therapy
2007-01-01 Offidani, M.; Ruggieri, M.; Polloni, C.; Corvatta, L.; Scortechini, I.; Montanari, M.; Piersantelli, M. N.; Catarini, M.; Burattini, M.; Olivieri, Attilio; Marconi, M.; Mele, M.; Visani, G. T.; Leoni, Pietro; Galieni, P.
Multicentre randomised GITMO-IIL trial in high-risk follicular lymphoma at diagnosis: rituximab-supplemented high-dose sequential chemotherapy is superior to CHOP-R in molecular remissions rate, EFS and PFS
2007-01-01 Ladetto, M.; De Marco, F.; Benedetti, F.; Vitolo, U.; Patti, C.; Rambaldi, A.; Liberati, A. M.; Musso, M.; Pulsoni, A.; Olivieri, Attilio; Pavone, E.; Pogliani, E.; Scalabrini, D. Rota; Gallamini, A.; Callea, V.; Ricca, I.; Boccadoro, M.; Majolino, I.; Corradini, P.; Gianni, A. M.; Tarella, C.
Reduced-intensity allogeneic stem cell transplantation for relapsed lymphomas: Clinical and molecular outcome is different between follicular lymphoma and chronic lymphocytic leukemia
2007-01-01 Corradini, P.; Dodero, A.; Dodero, A.; Farina, F. L.; Fanin, R.; Patriarca, F.; Miceli, R.; Matteucci, P.; Bregni, M.; Scime, R.; Nami, F.; Pogliani, E.; Locasciulli, A.; Milani, R.; Carniti, C.; Bacigalupo, A.; Rambaldi, A.; Bonifazi, F.; Olivieri, Attilio; Gianni, A. M.; Tarella, C.
Long-term outcome of RIC-allo SCT for myeloma
2007-01-01 Montefusco, V.; Ciceri, F.; Peccatori, J.; Farina, L.; Olivieri, Attilio; Hoenstaufen, K.; Deliliers, G. Lanbertenghi; Gianni, A. M.; Bregni, M.; Corradini, P.
Long-term outcome after reduced-intensity conditioning allogeneic transplantation in therapy-related myelodisplastc syndromes and acute myeloid leukemias
2007-01-01 Milani, R.; Dodero, A.; Piva, S.; Testi, A.; Tarella, C.; Bandini, G.; Bernardi, M.; Gianni, A. M.; Leoni, Pietro; Olivieri, Attilio; Corradini, P.
Bone localization of Hodgkin's lymphoma: Open biopsy versus fine needle CT-guided biopsy; A case report
2007-01-01 Attolico, I; Pizzuti, M.; Filardi, N.; Poggiaspalla, M.; Vertone, D.; Cimminiello, M.; Olivieri, Attilio
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional chemoimmunotherapy (CHOP-R) in high-risk follicular lymphoma at diagnosis: The superior molecular remission (MR) rate of R-HDS explains its better clinical performance
2007-01-01 Ladetto, M.; De Marco, F.; Benedetti, F.; Vitolo, U.; Patti, C.; Rambaldi, A.; Pulsoni, A.; Musso, M.; Liberati, A. M.; Olivieri, Attilio; Gallamini, A.; Pogliani, E.; Scalabrini, D. Rota; Callea, V.; Di Raimondo, F.; Pavone, V.; Tucci, A.; Cortelazzo, S.; Levis, A.; Boccadoro, M.; Majolino, I.; Pileri, A.; Gianni, A. M.; Passera, R.; Corradini, P.; Tarella, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Lyposomal doxorubicin (Caelyx), cyclophosphamide - Rituximab (DC-R) plus GM-CSF as a salvage therapy in B-diffuse large cell lymphoma (B-DLCL) after autologous stem cell transplantation (ASCT) failure. | 1-gen-2005 | Olivieri, Attilio; Montanari, M; Capelli, D; Scortechini, I; Gini, G; Trappolini, S; Leoni, Pietro | |
| Thalidomide, dexamethasone and pegylated-liposomal doxorubicin (ThaDD) for untreated multiple myeloma patients aged over 65 years. | 1-gen-2005 | Offidani, M; Corvatta, L; Marconi, M; Visani, G; Alesiani, F; Brunori, M; Galieni, P; Catarini, M; Burattini, M; Centurioni, R; Rupoli, S; Scortechini, Ar; Giuliodori, L; Candela, M; Capelli, D; Montanari, M; Olivieri, Attilio; Piersantelli, Mn; Leoni, Pietro | |
| Reduced-intensity conditioning (RIC) followed by allogeneic stem cell transplantation (SCT) for relapsed lymphomas: Impact of pre-transplantation factors on long-term outcome. | 1-gen-2005 | Corradini, P; Dodero, A; Bregni, M; Ciceri, F; Olivieri, Attilio; Farina, L; Valagussa, P; Scime, R; Locasciulli, A; Patriarca, F; Gianni, Am; Tarella, C. | |
| Reduced-intensity conditioning followed by allogeneic stem cell transplantation (allo-SCT) is an effective salvage treatment for peripheral T-cell non-Hodgkin's lymphoma (PTCL) | 1-gen-2005 | Corradini, P; Dodero, A; Bregni, M; Zallio, F; Farina, L; Rambaldi, A; Patriarca, F; Olivieri, Attilio; Bonifazi, F; Gianni, Am; Tarella, C. | |
| Rituximab-supplemented high-dose sequential chemotherapy (HDS) has superior response rate and event-free survival (EFS) compared to R-CHOP in poor risk follicular lymphoma (FL) at diagnosis: Results from a multicenter randomized GITMO trial. | 1-gen-2005 | Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Patti, C; Rambaldi, A; Liberati, Am; Musso, M; Pulsoni, A; Olivieri, Attilio; Pavone, E; Pogliani, E; Scalabrini, Dr; Gallamini, A; Callea, V; Mantoan, B; Boccadoro, M; Majolino, I; Corradini, P; Gianni, Am; Tarella, C. | |
| Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression | 1-gen-2006 | Olivieri, Attilio; SVEGLIATI BARONI, Silvia; Bacigalupo, A; Campelli, N; Piaggio, S; Luchetti, MICHELE MARIA; Trappolini, S; Poloni, Antonella; Leoni, Pietro; Gabrielli, Armando | |
| High incidence of EBV-reactivation and PTLD in adults receiving a cord blood transplant with reduced-intensity conditioning regimen | 1-gen-2006 | Gini, G; Poloni, Antonella; Mancini, G; Trappolini, S; Montanari, M; Capelli, D; Troiani, E; Scortechini, I; Re, R; Manzin, A; Leoni, Pietro; Olivieri, Attilio | |
| Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma | 1-gen-2006 | Majolino, I; Carnevalli, E; Locasciulli, A; Di Bartolomeo, P; Scime, R; Corradini, P; Selleri, M; Narni, F; Musso, M; Bregni, M; Olivieri, Attilio; De Fabritiis, P; Pogliani, L; Ruscio, C; Bacigalupo, A. | |
| Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin and Hodgkin's lymphomas | 1-gen-2006 | Corradini, P; Dodero, A; Bregni, M; Olivieri, Attilio; Valagussa, P; Farina, L; Milani, R; Scime, R; Rambaldi, A; Bonifazi, F; Patriarca, F; Locasciulli, A; Bacigalupo, A; Gianni, A; Tarella, C. | |
| A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. | 1-gen-2006 | Bacigalupo, Andrea; van Lint, Maria Teresa; Olivieri, Attilio; Casini, Marco; Angelucci, Emanuele; Narni, Franco; Selleri, Carmine; Di Bartolomeo, Paolo; Ciceri, Fabio; Fanin, Renato | |
| Reduced-intensity allogeneic stem cell transplantation is an effective salvage strategy for relapsed/refractory peripheral T-cell non-Hodgkin lymphomas | 1-gen-2007 | Corradini, P.; Dodero, A.; Narni, F.; Fanin, R.; Matteucci, P.; Ciceri, F.; Scime, R.; Farina, L.; Carniti, C.; Rambaldi, A.; Bonifazi, F.; Di Bartolomeo, P.; Olivieri, Attilio; Benedetti, F.; Console, G.; Angelucci, E.; Gianni, A. M.; Tarella, C. | |
| Early and late non relapse mortality in 2500 adults receiving ASCT for AML: a GITMO survey | 1-gen-2007 | Olivieri, Attilio; Bruno, B.; Brunori, M.; Bacigalupo, A.; Meloni, G.; Bosi, A. | |
| Clinical and molecular results of the multicenter randomized GITMO-IIL, trial in poor risk follicular lymphoma (FL) at diagnosis: Rituximab-supplemented high-dose sequential chemotherapy (R-HDS) is superior to CHOP-R in molecular remissions rate, EFS and PFS. | 1-gen-2006 | Ladetto, Marco; de Marco, Federica; Benedetti, Fabio; Vitolo, Umberto; Patti, Caterina; Rambaldi, Alessandro; Liberati, Anna Marina; Musso, Maurizio; Pulsoni, Alessandro; Olivieri, Attilio; Pavone, Enzo; Pogliani, Enrico; Scalabrini, Delia Rota; Gallamini, Andrea; Callea, Vincenzo; Ricca, Irene; Boccadoro, Mario; Majolino, Ignazio; Corradini, Paolo; Gianni, Alessandro M.; Tarella, Corrado | |
| Feasibility of autologous transplantation in elderly multiple myeloma (MM) patients receiving thadd as induction therapy | 1-gen-2007 | Offidani, M.; Ruggieri, M.; Polloni, C.; Corvatta, L.; Scortechini, I.; Montanari, M.; Piersantelli, M. N.; Catarini, M.; Burattini, M.; Olivieri, Attilio; Marconi, M.; Mele, M.; Visani, G. T.; Leoni, Pietro; Galieni, P. | |
| Multicentre randomised GITMO-IIL trial in high-risk follicular lymphoma at diagnosis: rituximab-supplemented high-dose sequential chemotherapy is superior to CHOP-R in molecular remissions rate, EFS and PFS | 1-gen-2007 | Ladetto, M.; De Marco, F.; Benedetti, F.; Vitolo, U.; Patti, C.; Rambaldi, A.; Liberati, A. M.; Musso, M.; Pulsoni, A.; Olivieri, Attilio; Pavone, E.; Pogliani, E.; Scalabrini, D. Rota; Gallamini, A.; Callea, V.; Ricca, I.; Boccadoro, M.; Majolino, I.; Corradini, P.; Gianni, A. M.; Tarella, C. | |
| Reduced-intensity allogeneic stem cell transplantation for relapsed lymphomas: Clinical and molecular outcome is different between follicular lymphoma and chronic lymphocytic leukemia | 1-gen-2007 | Corradini, P.; Dodero, A.; Dodero, A.; Farina, F. L.; Fanin, R.; Patriarca, F.; Miceli, R.; Matteucci, P.; Bregni, M.; Scime, R.; Nami, F.; Pogliani, E.; Locasciulli, A.; Milani, R.; Carniti, C.; Bacigalupo, A.; Rambaldi, A.; Bonifazi, F.; Olivieri, Attilio; Gianni, A. M.; Tarella, C. | |
| Long-term outcome of RIC-allo SCT for myeloma | 1-gen-2007 | Montefusco, V.; Ciceri, F.; Peccatori, J.; Farina, L.; Olivieri, Attilio; Hoenstaufen, K.; Deliliers, G. Lanbertenghi; Gianni, A. M.; Bregni, M.; Corradini, P. | |
| Long-term outcome after reduced-intensity conditioning allogeneic transplantation in therapy-related myelodisplastc syndromes and acute myeloid leukemias | 1-gen-2007 | Milani, R.; Dodero, A.; Piva, S.; Testi, A.; Tarella, C.; Bandini, G.; Bernardi, M.; Gianni, A. M.; Leoni, Pietro; Olivieri, Attilio; Corradini, P. | |
| Bone localization of Hodgkin's lymphoma: Open biopsy versus fine needle CT-guided biopsy; A case report | 1-gen-2007 | Attolico, I; Pizzuti, M.; Filardi, N.; Poggiaspalla, M.; Vertone, D.; Cimminiello, M.; Olivieri, Attilio | |
| Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional chemoimmunotherapy (CHOP-R) in high-risk follicular lymphoma at diagnosis: The superior molecular remission (MR) rate of R-HDS explains its better clinical performance | 1-gen-2007 | Ladetto, M.; De Marco, F.; Benedetti, F.; Vitolo, U.; Patti, C.; Rambaldi, A.; Pulsoni, A.; Musso, M.; Liberati, A. M.; Olivieri, Attilio; Gallamini, A.; Pogliani, E.; Scalabrini, D. Rota; Callea, V.; Di Raimondo, F.; Pavone, V.; Tucci, A.; Cortelazzo, S.; Levis, A.; Boccadoro, M.; Majolino, I.; Pileri, A.; Gianni, A. M.; Passera, R.; Corradini, P.; Tarella, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1475
Data di pubblicazione
- 2020 - 202581
- 2010 - 2019662
- 2000 - 2009566
- 1990 - 1999141
- 1981 - 198925
Editore
- BMJ / British Medical Journal Pub...1
- CSIRO Publishing:150 Oxford Stree...1
- Elsevier1
- Elsevier Science Limited:Oxford F...1
- Mary Ann Liebert Incorporated:2 M...1
- Oxford University Press:Journals ...1
- Parthenon Publishing:Richmond Hou...1
Rivista
- NEUROLOGICAL SCIENCES137
- BLOOD94
- BONE MARROW TRANSPLANTATION62
- HAEMATOLOGICA46
- ANNALS OF THE RHEUMATIC DISEASES43
- ITALIAN JOURNAL OF ANATOMY AND EM...40
- ANTICANCER RESEARCH33
- ITALIAN JOURNAL OF BIOCHEMISTRY31
- ACTA OPHTHALMOLOGICA27
- BIOCHIMICA CLINICA22
Keyword
- DBS4
- mortar3
- STN3
- brick2
- DBS STN2
- geopolymer2
- IAQ2
- language disorders2
- mechanical properties2
- P3002
Lingua
- eng954
- ita108
- ger1
- spa1
Accesso al fulltext
- no fulltext1473
- open1
- reserved1